Plasma Cabozantinib Level Measurement in Patients with Renal Cell and Hepatocellular Carcinomas Using a Simple HPLC–UV Method Suitable for Clinical Application

Cabozantinib, which is used to treat renal cell and hepatocellular carcinomas, is often associated with dose-dependent adverse events. Monitoring the levels of cabozantinib in the blood may maximize the therapeutic effect and prevent serious adverse events. In this study, we developed a high-perform...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasu, Takeo, Gando, Yoshito, Nishijima, Ryosuke, Ikuta, Risa, Suzuki, Motofumi, Shirota, Mikio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217095/
https://www.ncbi.nlm.nih.gov/pubmed/37232825
http://dx.doi.org/10.3390/curroncol30050367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217095/
https://www.ncbi.nlm.nih.gov/pubmed/37232825
http://dx.doi.org/10.3390/curroncol30050367

Ejemplares similares